Following this presentation, you will be able to:
- Define polypharmacy
- State three of the potential negative outcomes from polypharmacy
- State the risk factors associated with adverse drug events
- Cite at least two models used to safely deprescribe
- Describe how to identify opportunities for safely deprescribing in a medication regimen
- Describe the role of the older adult in deprescribing
- Define your role as a facilitator in assisting the deprescribing of unnecessary medications to reduce the risk for harm
Alan Lukazewski, PharmD
Tim Bartholow, MD, VP, Chief Medical Officer, WEA Trust, Madison, WI
Eric Buxton, PhD, UW-Madison, School of Pharmacy, Madison, WI
Alan Lukazewski, RPh, Director of Clinical Pharmacy, Neugen Healthcare, Madison, WI
Kari Trapskin, PharmD, Pharmacy Society of Wisconsin, Madison, WI
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Pharmacy Society of Wisconsin. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin–Madison ICEP designates this a knowledge based activity for 0.75 hours or 0.075 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
UAN: JA0000358-9999-19-014-H04-P, (0.75 Hour or 0.075 CEUs)
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this online activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.